EP0509066A4 - Composition and method for protecting the heart during reperfusion - Google Patents

Composition and method for protecting the heart during reperfusion

Info

Publication number
EP0509066A4
EP0509066A4 EP19910916208 EP91916208A EP0509066A4 EP 0509066 A4 EP0509066 A4 EP 0509066A4 EP 19910916208 EP19910916208 EP 19910916208 EP 91916208 A EP91916208 A EP 91916208A EP 0509066 A4 EP0509066 A4 EP 0509066A4
Authority
EP
European Patent Office
Prior art keywords
protecting
composition
heart during
during reperfusion
reperfusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910916208
Other versions
EP0509066A1 (en
Inventor
Austin L. Shug
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHUG Austin L
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0509066A1 publication Critical patent/EP0509066A1/en
Publication of EP0509066A4 publication Critical patent/EP0509066A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP19910916208 1990-09-10 1991-09-09 Composition and method for protecting the heart during reperfusion Withdrawn EP0509066A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58012790A 1990-09-10 1990-09-10
US580127 1995-12-28

Publications (2)

Publication Number Publication Date
EP0509066A1 EP0509066A1 (en) 1992-10-21
EP0509066A4 true EP0509066A4 (en) 1992-11-25

Family

ID=24319829

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910916208 Withdrawn EP0509066A4 (en) 1990-09-10 1991-09-09 Composition and method for protecting the heart during reperfusion

Country Status (4)

Country Link
EP (1) EP0509066A4 (en)
AU (1) AU8513191A (en)
CA (1) CA2068333A1 (en)
WO (1) WO1992004023A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9512100D0 (en) * 1995-06-14 1995-08-09 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5656608B1 (en) * 1995-02-23 2000-09-26 Novartis Nutrition Ltd Amino acid compositions and methods of treatment using same
US5824662A (en) * 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
PL332413A1 (en) 1996-09-27 1999-09-13 Guilford Pharm Inc Compositions containing inhibitors of naaladase as well as methods of treating glutamatic anomaly and influencing neuronic functions among animals
JPWO2003068215A1 (en) * 2002-02-14 2005-06-02 味の素株式会社 Mitochondrial drugs
DE10262084B4 (en) * 2002-05-17 2009-12-24 Dr. Franz Köhler Chemie GmbH Protective solution for the prevention of ischemic damage
KR20080046177A (en) 2005-08-19 2008-05-26 시게오 오타 Scavenger of harmful active oxygen and/or free radical in living body

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318446A1 (en) * 1987-10-29 1989-05-31 Ab Erik Vinnars Amino acid composition for parenteral nutritional support

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2372626A1 (en) * 1976-12-02 1978-06-30 Sertog THERAPEUTIC COMPOSITIONS BASED ON A PLANT EXTRACT AND AMINO ACIDS
US4780475A (en) * 1986-02-03 1988-10-25 Cerra Frank B Preparation for the prevention of catabolism
JPH01216924A (en) * 1988-02-24 1989-08-30 Ajinomoto Co Inc Therapeutic agent for hepatic disorder

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318446A1 (en) * 1987-10-29 1989-05-31 Ab Erik Vinnars Amino acid composition for parenteral nutritional support

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DIALOG INFORMATION SERVICES FILE NO. 5: BIOSIS 1969-1992 ACCESSION NO. 5768771 E. SHIBATA: 'Myocardial glutamate metabolism during reperfusion and its protecting effect against the reperfusion injury' *
See also references of WO9204023A1 *

Also Published As

Publication number Publication date
WO1992004023A1 (en) 1992-03-19
EP0509066A1 (en) 1992-10-21
CA2068333A1 (en) 1992-03-11
AU8513191A (en) 1992-03-30

Similar Documents

Publication Publication Date Title
EP0448300A3 (en) Method and composition for coiontophoresis
HUT65710A (en) Method and composition for disinfecting contact-lenses
EG19392A (en) Improved method for omprazole symthesis
GB9521654D0 (en) 1-N-Ethyl gentamicin derivatives and the method for preparing thereof
EP0278505A3 (en) Hair protection composition and method
HK13497A (en) Anti-coalescent ink composition and method for making the same
ZA931297B (en) Cytoprotective compositions and methods for preparing and using same
GB9104546D0 (en) Method and composition for enhancing performance
HUT58453A (en) Fungicidal compositions and process for applying same
EP0656791A4 (en) Therapeutic compositions and methods using pqq.
EP0464545A3 (en) Paste composition and method for preparing the same
EP0509066A4 (en) Composition and method for protecting the heart during reperfusion
GB9006671D0 (en) Diagnostic method and compositions
ZA919577B (en) Composition and method for preventing fluorosis
EP0326763A3 (en) Cathodic protection method and compositions
ZA912113B (en) Method and composition for water treatment
GB9016171D0 (en) Fungicidal compositions and method
GB9102879D0 (en) Method,apparatus and composition
GB9026896D0 (en) Method and composition
ZA90663B (en) Herbicidal method and composition
ZA913994B (en) Antiprotozoal composition and process for preparing the same
GB9010014D0 (en) Method and composition
GB9012083D0 (en) Method and composition
GB9020384D0 (en) Method and composition
GB9008585D0 (en) Composition and method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19920616

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE FR GB LI NL

A4 Supplementary search report drawn up and despatched

Effective date: 19921003

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): CH DE FR GB LI NL

17Q First examination report despatched

Effective date: 19930414

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SHUG, AUSTIN L.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19941004